GB1343276A - Protease inhibitors and methods for their preparation - Google Patents

Protease inhibitors and methods for their preparation

Info

Publication number
GB1343276A
GB1343276A GB1343276DA GB1343276A GB 1343276 A GB1343276 A GB 1343276A GB 1343276D A GB1343276D A GB 1343276DA GB 1343276 A GB1343276 A GB 1343276A
Authority
GB
United Kingdom
Prior art keywords
april
molecular weight
inhibitor
protease
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of GB1343276A publication Critical patent/GB1343276A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1343276 Protease inhibitor ASTRA LAKEMEDEL AB 19 April 1971 [1 April 1970 28 Jan 1971] 15530/70 and 3426/71 Heading A5B [Also in Division C3] A protease inhibitor comprising a trypsin inhibiting fraction of molecular weight c. 1400 and an isoelectric point above pH 10, and a chymotrypsin inhibiting fraction of molecular weight not greater than about 1000 is obtained by cultivating Streptomyces violascens NRRL 3859 under aerobic submerged conditions and isolating the inhibitor from the broth by conventional methods. The product may be put up into conventional pharmaceutical forms and used for the usual purposes, e.g. the treatment of shock, pancreatic disorders and blood clots. It is also stated to be active against Protease I and may be used as an antidote therefor.
GB1343276D 1970-04-01 1971-04-19 Protease inhibitors and methods for their preparation Expired GB1343276A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1553070 1970-04-01

Publications (1)

Publication Number Publication Date
GB1343276A true GB1343276A (en) 1974-01-10

Family

ID=10060765

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1343276D Expired GB1343276A (en) 1970-04-01 1971-04-19 Protease inhibitors and methods for their preparation

Country Status (1)

Country Link
GB (1) GB1343276A (en)

Similar Documents

Publication Publication Date Title
Reysset et al. Characterization of an intracellular protease in B., subtilis during sporulation
ES8104278A1 (en) Inhibition of thromboxane synthetase by 3-(1-Imidazolylalkyl) indoles
UA6345A1 (en) METHOD OF OBTAINING AVERMECTIN DERIVATIVE
IE36629B1 (en) Pyrazolo-pyrimidines useful as zanthine oxidase inhibitor
RU92016490A (en) NEW 2-SAHARINILMETHIL (ARYL AND AROXY) ACETATES APPLICABLE AS AN INHIBITORS PROTEOLYTIC ENZYMES, THEIR COMPOSITION AND METHOD
GB1537509A (en) Method of preparing a component consisting of sugar lipid and protein derived from pseudomonas aeruginosa which possesses anti-tumor and interferon-inducing properties
GB1495289A (en) Pharmaceutically active proteinaceous compounds
GB1343276A (en) Protease inhibitors and methods for their preparation
GB1414696A (en) Protease inhibitor and a method for its production
NO920555D0 (en) POLYHYDROCYCYCLOPENTAND DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND THERAPEUTICAL USE OF THE PREPARATIONS
GB1147471A (en) Process for preparing a lipolytic enzyme
GB1221235A (en) A process for the production of uricase
Chibata et al. ɛ-Lysine Acylase in Bacteria
ES405205A1 (en) Procedure for the preparation of an enzymatic substance with thrombolic activity. (Machine-translation by Google Translate, not legally binding)
ES376787A1 (en) Enzymatic products which optimise the viscosity of mucuses and their applications
GB1400851A (en) Triidothyroalkyl compounds their method of preparation and therapeutical compositions containing such compounds
JPS55167275A (en) Preparation of amidinophenyl ester derivative
ES413425A1 (en) Pepsinostrepins, novel protease inhibitors from streptomyces
JPS527488A (en) Preparation of l-threonine by fermentation
GB1394231A (en) Process for the production of pepstatins having anti-pepsin activity
IE42220L (en) Dibenzocycloheptenylidenepiperidine derivative.
SU122579A1 (en) Method of preventing inactivation of native penicillin
GB1389859A (en) Salts of fluorinated amino acid with optically active acids or bases
FR2183837A1 (en) Rifamycin B prodn - by fermentation of nocardia asiatica 9NA 2739
JPS5461128A (en) Peptide derivative

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees